Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8529 |
High Similarity |
NPD5124 |
Phase 1 |
0.8529 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8162 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8095 |
Intermediate Similarity |
NPD920 |
Approved |
0.8069 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8043 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7947 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD919 |
Approved |
0.7891 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.782 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7793 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7687 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7687 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7667 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7643 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7643 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7638 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7612 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7564 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7554 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7554 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7552 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7535 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4626 |
Approved |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7482 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7482 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7452 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7385 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7379 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7261 |
Intermediate Similarity |
NPD37 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1934 |
Approved |
0.726 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7256 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7214 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4140 |
Approved |
0.719 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7178 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD290 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD17 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7107 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2415 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7042 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7024 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD6273 |
Approved |
0.6985 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.698 |
Remote Similarity |
NPD6653 |
Approved |
0.6978 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6972 |
Remote Similarity |
NPD1608 |
Approved |
0.6968 |
Remote Similarity |
NPD1511 |
Approved |
0.6968 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD5353 |
Approved |
0.6954 |
Remote Similarity |
NPD6099 |
Approved |
0.6954 |
Remote Similarity |
NPD6100 |
Approved |
0.695 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD987 |
Approved |
0.6939
|
Remote Similarity |
NPD3764 |
Approved |